HEPATO CELLULAR CARCINOMA
Clinical trials for HEPATO CELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEPATO CELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for HEPATO CELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can immunotherapy plus liver treatments open the door to transplants for more cancer patients?
Disease control Recruiting nowThis study is testing whether combining immunotherapy drugs (tremelimumab and durvalumab) with liver-directed procedures like TACE, TARE, or RFA can shrink liver cancer enough to make patients eligible for a liver transplant. The trial enrolls 41 adults with hepatocellular carcin…
Matched conditions: HEPATO CELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Ju Dong Yang • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could your nerves predict liver cancer? new study investigates
Knowledge-focused Recruiting nowThis study looks at how the autonomic nervous system (which controls automatic body functions) might be involved in liver cancer. Researchers will measure nerve activity and psychological traits in 100 adults with cirrhosis to find new ways to detect liver cancer earlier. The goa…
Matched conditions: HEPATO CELLULAR CARCINOMA
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC